Relonchem Receives Marketing Authorization for Two Products
17 Nov 2025 //
CAPITALMARKET
Marksans Pharma`s UK Arm, Relonchem, Secures MHRA Approval
06 Nov 2025 //
INDPHARMAPOST
UK Relonchem receives authorization for Levonorgestrel 1.5 mg Tablets
06 Aug 2024 //
#N/A

Market Place
Sourcing Support